Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

REHANA LATIF

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1184638140
CMS profile
7707
Location
BRONXVILLE, NY

General Payments · PY2018–2024

$9,448.15

  • Reported across 500 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$882.76

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $882.76 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Vanda Pharmaceuticals Inc. $348.28 10
ITI, Inc. $183.35 8
ABBVIE INC. $172.72 9
Lundbeck LLC $80.88 3
Neurocrine BioSciences, Inc. $43.38 2
Alkermes, Inc. $27.81 1
Takeda Pharmaceuticals U.S.A., Inc. $26.34 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,948.90 93
PY2019 $1,534.92 79
PY2020 $580.88 39
PY2021 $1,866.82 124
PY2022 $1,131.24 61
PY2023 $1,502.63 70
PY2024 $882.76 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $24.90 01/19/2024 Food and Beverage Undisputed 01/23/2026 1104140416 CMS
ABBVIE INC. $16.72 02/01/2024 Food and Beverage Undisputed 01/23/2026 1104140418 CMS
ABBVIE INC. $18.53 02/29/2024 Food and Beverage Undisputed 01/23/2026 1104140420 CMS
ABBVIE INC. $15.39 03/15/2024 Food and Beverage Undisputed 01/23/2026 1104140422 CMS
ABBVIE INC. $16.48 03/28/2024 Food and Beverage Undisputed 01/23/2026 1104140424 CMS
ABBVIE INC. $26.41 04/18/2024 Food and Beverage Undisputed 01/23/2026 1104140426 CMS
ABBVIE INC. $15.89 06/20/2024 Food and Beverage Undisputed 01/23/2026 1104140428 CMS
ABBVIE INC. $18.78 10/17/2024 Food and Beverage Undisputed 01/23/2026 1104140430 CMS
ABBVIE INC. $19.62 12/12/2024 Food and Beverage Undisputed 01/23/2026 1104140432 CMS
Alkermes, Inc. $27.81 08/01/2024 Food and Beverage Undisputed 01/23/2026 1120539027 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.67 02/01/2024 Food and Beverage Undisputed 01/23/2026 1143263108 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.12 02/29/2024 Food and Beverage Undisputed 01/23/2026 1143263112 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.62 03/21/2024 Food and Beverage Undisputed 01/23/2026 1143263116 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.36 03/29/2024 Food and Beverage Undisputed 01/23/2026 1143263120 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.97 05/30/2024 Food and Beverage Undisputed 01/23/2026 1143263123 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.38 09/17/2024 Food and Beverage Undisputed 01/23/2026 1143263127 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $30.13 10/04/2024 Food and Beverage Undisputed 01/23/2026 1143263131 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $34.10 11/07/2024 Food and Beverage Undisputed 01/23/2026 1143263135 CMS
Lundbeck LLC $24.11 02/22/2024 Food and Beverage Undisputed 01/23/2026 1145937982 CMS
Lundbeck LLC $27.17 05/22/2024 Food and Beverage Undisputed 01/23/2026 1145937984 CMS
Lundbeck LLC $29.60 10/10/2024 Food and Beverage Undisputed 01/23/2026 1145937986 CMS
Neurocrine Biosciences, Inc. $22.25 04/04/2024 Food and Beverage Undisputed 01/23/2026 1150850368 CMS
Neurocrine Biosciences, Inc. $21.13 08/29/2024 Food and Beverage Undisputed 01/23/2026 1150854225 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.34 07/18/2024 Food and Beverage Undisputed 01/23/2026 1137614308 CMS
Vanda Pharmaceuticals Inc. $22.81 06/14/2024 Food and Beverage Undisputed 01/23/2026 1133909990 CMS
Vanda Pharmaceuticals Inc. $23.33 06/27/2024 Food and Beverage Undisputed 01/23/2026 1133909992 CMS
Vanda Pharmaceuticals Inc. $12.61 07/18/2024 Food and Beverage Undisputed 01/23/2026 1133909994 CMS
Vanda Pharmaceuticals Inc. $16.40 07/25/2024 Food and Beverage Undisputed 01/23/2026 1133909996 CMS
Vanda Pharmaceuticals Inc. $33.64 08/23/2024 Food and Beverage Undisputed 01/23/2026 1133909998 CMS
Vanda Pharmaceuticals Inc. $126.02 09/05/2024 Food and Beverage Undisputed 01/23/2026 1133910000 CMS
Vanda Pharmaceuticals Inc. $33.91 09/06/2024 Food and Beverage Undisputed 01/23/2026 1133910002 CMS
Vanda Pharmaceuticals Inc. $31.06 09/26/2024 Food and Beverage Undisputed 01/23/2026 1133910004 CMS
Vanda Pharmaceuticals Inc. $22.36 11/12/2024 Food and Beverage Undisputed 01/23/2026 1133910006 CMS
Vanda Pharmaceuticals Inc. $26.14 11/21/2024 Food and Beverage Undisputed 01/23/2026 1133910008 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.